Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that its Board of Directors has approved a stock repurchase program for up to an additional aggregate ...

The new stock repurchase program may signal a lack of ... Cytek’s products are for research use only and not for use in diagnostic procedures (other than Cytek’s Northern Lights-CLC system ...

Dec. 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that its Board of Directors has approved a stock repurchase ...

Insider Trading Policies. As previously discussed in our Winter 2022-2023 Corporate Communicator, the Securities and Exchange Commission ...

International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) is pleased to announce that IPC ...

Korea boosts foreign investment with 75% cash grants and ISA limit expansion Foreign investment incentives expanded with ...

CECO Environmental Corp. (Nasdaq: CECO) (together with its consolidated subsidiaries and affiliates, "CECO"), a leading environmentally focused, diversified ...

Atlanticus Holdings Co. (NASDAQ:ATLCP – Get Free Report) was the recipient of a large increase in short interest during the month of December. As of December 15th, there was short interest totalling 2 ...

Qifu Technology said its board of directors approved a new share buyback plan to purchase up to $450 million of American Depositary Shares or Class A ordinary shares. The credit-tech platform in China ...